Cargando…
The immunologically high-risk kidney recipient in the early post-COVID-19 period. To do or not to do? A case report
Kidney transplantation is nowadays the treatment of choice for end-stage kidney disease (ESKD), and it is the most performed organ transplantation. During the COVID-19 pandemic, kidney-transplant recipients appeared to be at higher risk of morbidity and mortality due to severe forms of illness. The...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076652/ https://www.ncbi.nlm.nih.gov/pubmed/37035338 http://dx.doi.org/10.3389/fmed.2023.1147835 |